Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis

Case Reports in Gastroenterology

Volumn 6, Issue 2, 2012, Pages 429-437

  Lam, Mindy C W ^a   Singham, Janakie ^a   Hegele, Robert A ^b   Riazy, Maziar ^a   Hiob, Matti A ^a   Francis, Gordon ^a   Steinbrecher, Urs P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

APOB; Familial hypobetalipoproteinemia; Nonalcoholic steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; FERRITIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; DISEASE SEVERITY; EXERCISE; FAMILIAL HYPOBETALIPOPROTEINEMIA; FERRITIN BLOOD LEVEL; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HUMAN; LOW FAT DIET; MALE; NONALCOHOLIC FATTY LIVER; PHENOTYPE; PRIORITY JOURNAL;

EID: 84866660570     PISSN: None     EISSN: 16620631     Source Type: Journal    
DOI: 10.1159/000339761     Document Type: Article

References (63)

1. Steinberg D, Grundy SM, Mok HY, et al: Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia. J Clin Invest 1979;64:292-301. (Pubitemid 9216546)
2. Heiss G, Tamir I, Davis CE, et al: Lipoprotein-cholesterol distributions in selected North American populations: The lipid research clinics program prevalence study. Circulation 1980;61:302-315. (Pubitemid 10214988)
3. Contois J, McNamara JR, Lammi-Keefe C, et al: Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: Results from the Framingham Offspring Study. Clin Chem 1996;42:507-514. (Pubitemid 26111867)
4. Cladaras C, Hadzopoulou-Cladaras M, Nolte RT, et al: The complete sequence and structural analysis of human apolipoprotein B-100: Relationship between apoB-100 and apoB-48 forms. EMBO J 1986;5: 3495-3507.
5. Herbert PN, Hyams JS, Bernier DN, et al: Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis. J Clin Invest 1985;76:403-412. (Pubitemid 15227498)
6. Lusis AJ, West R, Mehrabian M, et al: Cloning and expression of apolipoprotein B, the major protein of low and very low density lipoproteins. Proc Natl Acad Sci USA 1985;82:4597-4601. (Pubitemid 16239610)
7. Tarugi P, Averna M, Di Leo E, et al: Molecular diagnosis of hypobetalipoproteinemia: An ENID review. Atherosclerosis 2007;195:e19-e27. (Pubitemid 350087974)
8. Hegele RA: Plasma lipoproteins: Genetic influences and clinical implications. Nat Rev Genet 2009;10: 109-121.
9. Johansen CT, Kathiresan S, Hegele RA: Genetic determinants of plasma triglycerides. J Lipid Res 2011;52: 189-206.
10. Musunuru K, Pirruccello JP, Do R, et al: Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med 2010;363:2220-2227.
11. Zhao Z, Tuakli-Wosornu Y, Lagace TA, et al: Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am J Hum Genet 2006;79:514-523. (Pubitemid 44384260)
12. Raal FJ, Santos RD, Blom DJ, et al: Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: A randomised, double-blind, placebo-controlled trial. Lancet 2010;375:998-1006.
13. Samaha FF, McKenney J, Bloedon LT, et al: Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia. Nat Clin Pract Cardiovasc Med 2008;5:497-505.
14. Crunkhorn S: Trial watch: PCSK9 antibody reduces LDL cholesterol. Nat Rev Drug Discov 2012;11:11.
15. Young SG, Bertics SJ, Curtiss LK, et al: Genetic analysis of a kindred with familial hypobetalipopro-teinemia. Evidence for two separate gene defects: One associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100. J Clin Invest 1987;79:1842-1851. (Pubitemid 17117293)
16. Linton MF, Pierotti V, Young SG: Reading-frame restoration with an apolipoprotein B gene frameshift mutation. Proc Natl Acad Sci USA 1992;89:11431-11435.
17. Collins DR, Knott TJ, Pease RJ, et al: Truncated variants of apolipoprotein B cause hypobetalipo-proteinaemia. Nucleic Acids Res 1988;16:8361-8375.
18. Krul ES, Kinoshita M, Talmud P, et al: Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia. Arteriosclerosis 1989;9:856-868. (Pubitemid 20002218)
19. Parhofer KG, Barrett PH, Bier DM, Schonfeld G: Lipoproteins containing the truncated apolipoprotein, apo B-89, are cleared from human plasma more rapidly than apo B-100-containing lipoproteins in vivo. J Clin Invest 1992;89:1931-1937.
20. Young SG, Hubl ST, Chappell DA, et al: Familial hypobetalipoproteinemia associated with a mutant species of apolipoprotein B (B-46). N Engl J Med 1989;320:1604-1610. (Pubitemid 19154575)
21. Young SG, Hubl ST, Smith RS, et al: Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins. J Clin Invest 1990;85:933-942. (Pubitemid 20087499)
22. Huang LS, Ripps ME, Korman SH, et al: Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination. J Biol Chem 1989;264:11394-11400. (Pubitemid 19168876)
23. Welty FK, Hubl ST, Pierotti VR, Young SG: A truncated species of apolipoprotein B (B67) in a kindred with familial hypobetalipoproteinemia. J Clin Invest 1991;87:1748-1754.
24. McCormick SP, Fellowes AP, Walmsley TA, George PM: Apolipoprotein B-32: A new truncated mutant of human apolipoprotein B capable of forming particles in the low density lipoprotein range. Biochim Biophys Acta 1992;1138:290-296.
25. Talmud PJ, Converse C, Krul E, et al: A novel truncated apolipoprotein B (apo B55) in a patient with familial hypobetalipoproteinemia and atypical retinitis pigmentosa. Clin Genet 1992;42:62-70.
26. Yue P, Yuan B, Gerhard DS, et al: Novel mutations of apoB cause apoB truncations undetectable in plasma and familial hypobetalipoproteinemia. Hum Mutat 2002;20:110-116. (Pubitemid 34810066)
27. Hegele RA, Miskie BA: Acanthocytosis in a patient with homozygous familial hypobetalipoproteinemia due to a novel apoB splice site mutation. Clin Genet 2002;61:101-103. (Pubitemid 36372614)
28. Tarugi P, Lonardo A, Ballarini G, et al: Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B. Gastroenterology 1996;111:1125-1133. (Pubitemid 26327617)
29. Tarugi P, Lonardo A, Gabelli C, et al: Phenotypic expression of familial hypobetalipoproteinemia in three kindreds with mutations of apolipoprotein B gene. J Lipid Res 2001;42:1552-1561. (Pubitemid 33020087)
30. Pulai JI, Zakeri H, Kwok PY, et al: Donor splice mutation (665 + 1 G-T) in familial hypobetalipoprotein-emia with no detectable apoB truncation. Am J Med Genet 1998;80:218-220.
31. Talmud P, King-Underwood L, Krul E, et al: The molecular basis of truncated forms of apolipoprotein B in a kindred with compound heterozygous hypobetalipoproteinemia. J Lipid Res 1989;30:1773-1779. (Pubitemid 20024856)
32. Welty FK, Guida KA, Andersen JJ: Donor splice-site mutation (210 + 1G-C) in the apoB gene causes a very low level of apoB-100 and LDL cholesterol. Arterioscler Thromb Vasc Biol 2001;21:1864-1865.
33. Welty FK, Ordovas J, Schaefer EJ, et al: Identification and molecular analysis of two apoB gene mutations causing low plasma cholesterol levels. Circulation 1995;92:2036-2040.
34. Pullinger CR, Hillas E, Hardman DA, et al: Two apolipoprotein B gene defects in a kindred with hypobetalipoproteinemia, one of which results in a truncated variant, apoB-61, in VLDL and LDL. J Lipid Res 1992;33:699-710.
35. Hardman DA, Pullinger CR, Hamilton RL, et al: Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia. J Clin Invest 1991;88:1722-1729.
36. Young SG, Pullinger CR, Zysow BR, et al: Four new mutations in the apolipoprotein B gene causing hypobetalipoproteinemia, including two different frameshift mutations that yield truncated apolipoprotein B proteins of identical length. J Lipid Res 1993;34:501-507. (Pubitemid 23095376)
37. Talmud PJ, Krul ES, Pessah M, et al: Donor splice mutation generates a lipid-associated apolipoprotein B-27.6 in a patient with homozygous hypobetalipoproteinemia. J Lipid Res 1994;35:468-477. (Pubitemid 24081860)
38. Tarugi P, Averna M: Hypobetalipoproteinemia: Genetics, biochemistry, and clinical spectrum. Adv Clin Chem 2011;54:81-107.
39. Groenewegen WA, Averna MR, Pulai J, et al: Apolipoprotein B-38.9 does not associate with apo[a] and forms two distinct HDL density particle populations that are larger than HDL. J Lipid Res 1994;35: 1012-1025.
40. Zhu XF, Noto D, Seip R, et al: Organ loci of catabolism of short truncations of apoB. Arterioscler Thromb Vasc Biol 1997;17:1032-1038. (Pubitemid 27260320)
41. Chen Z, Saffitz JE, Latour MA, Schonfeld G: Truncated apo B-70.5-containing lipoproteins bind to megalin but not the LDL receptor. J Clin Invest 1999;103:1419-1430. (Pubitemid 29535498)
42. Parhofer KG, Daugherty A, Kinoshita M, Schonfeld G: Enhanced clearance from plasma of low density lipoproteins containing a truncated apolipoprotein, apoB-89. J Lipid Res 1990;31:2001-2007.
43. Linton MF, Farese RV Jr, Young SG: Familial hypobetalipoproteinemia. J Lipid Res 1993;34:521-541. (Pubitemid 23118753)
44. Chen Z, Fitzgerald RL, Li G, et al: Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele. J Lipid Res 2004;45:155-163. (Pubitemid 38176626)
45. Elias N, Patterson BW, Schonfeld G: In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene. Arterioscler Thromb Vasc Biol 2000;20: 1309-1315. (Pubitemid 30262932)
46. Yue P, Tanoli T, Wilhelm O, et al: Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21. Metabolism 2005;54:682-688. (Pubitemid 40585659)
47. Yuan B, Neuman R, Duan SH, et al: Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22. Am J Hum Genet 2000;66:1699-1704. (Pubitemid 30463090)
48. Horton JD, Cohen JC, Hobbs HH: Molecular biology of PCSK9: Its role in LDL metabolism. Trends Biochem Sci 2007;32:71-77. (Pubitemid 46199197)
49. Tarugi P, Lonardo A: Heterozygous familial hypobetalipoproteinemia associated with fatty liver. Am J Gastroenterol 1997;92:1400-1402. (Pubitemid 27328619)
50. Lonardo A, Tarugi P, Ballarini G, Bagni A: Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma. Dig Dis Sci 1998;43:2489-2492. (Pubitemid 28531325)
51. Schonfeld G, Patterson BW, Yablonskiy DA, et al: Fatty liver in familial hypobetalipoproteinemia: Triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. J Lipid Res 2003;44:470-478. (Pubitemid 37279694)
52. Whitfield AJ, Barrett PH, Robertson K, et al: Liver dysfunction and steatosis in familial hypobetalipo-proteinemia. Clin Chem 2005;51:266-269. (Pubitemid 40024057)
53. Burnett JR, Shan J, Miskie BA, et al: A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia. J Biol Chem 2003;278:13442-13452. (Pubitemid 36800118)
54. Harada N, Soejima Y, Taketomi A, et al: Recurrent familial hypobetalipoproteinemia-induced nonalcoholic fatty liver disease after living donor liver transplantation. Liver Transpl 2009;15:806-809.
55. Traber MG, Sokol RJ, Ringel SP, et al: Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy. N Engl J Med 1987;317:262-265. (Pubitemid 17100104)
56. Kayden HJ, Traber MG: Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 1993;34:343-358. (Pubitemid 23095362)
57. Buonuomo PS, Ruggiero A, Valeriani M, Mariotti P: Familial hypobetalipoproteinemia: Early neurological, hematological, and ocular manifestations in two affected twins responding to vitamin supplementation. Curr Opin Pediatr 2009;21:824-827.
58. Granot E, Deckelbaum RJ: Hypocholesterolemia in childhood. J Pediatr 1989;115:171-185. (Pubitemid 19190334)
59. Scott BB, Miller JP, Losowsky MS: Hypobetalipoproteinaemia - a variant of the Bassen-Kornzweig syndrome. Gut 1979;20:163-168.
60. Hegele RA, Angel A: Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy. Can Med Assoc J 1985;132:41-44. (Pubitemid 15198682)
61. Bishara S, Merin S, Cooper M, et al: Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia. Br J Ophthalmol 1982;66:767-770. (Pubitemid 13254878)
62. Chowers I, Banin E, Merin S, Cooper M, Granot E: Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in sabetalipoproteinaemia and hypobetalipopro-teinaemia patients. Eye (Lond) 2001;15:525-530. (Pubitemid 32755726)
63. Burnett JR, Hooper AJ: Common and rare gene variants affecting plasma LDL cholesterol. Clin Biochem Rev 2008;29:11-26.